| Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer AA Bhat, A Goyal, R Thapa, I Kazmi, SI Alzarea, M Singh, S Rohilla, ... Cytokine 171, 156376, 2023 | 56 | 2023 |
| Exploring the mechanical perspective of a new anti-tumor agent: melatonin S Rohilla, M Singh, S Priya, WH Almalki, SM Haniffa, V Subramaniyan, ... Journal of Environmental Pathology, Toxicology and Oncology 42 (1), 2023 | 52 | 2023 |
| Recent developments and challenges in molecular-targeted therapy of non-small-cell lung cancer S Rohilla, M Singh, SI Alzarea, WH Almalki, FA Al-Abbasi, I Kazmi, O Afzal, ... Journal of Environmental Pathology, Toxicology and Oncology 42 (1), 2023 | 39 | 2023 |
| Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID‐19 S Rohilla Drug development research 82 (1), 12-26, 2021 | 27 | 2021 |
| Synthesis and Evaluation of a New Series of 8‐(2‐Nitroaryl) Xanthines as Adenosine Receptor Ligands R Bansal, G Kumar, S Rohilla, KN Klotz, S Kachler, LC Young, AL Harvey Drug development research 77 (5), 241-250, 2016 | 16 | 2016 |
| Synthesis and pharmacological characterization of novel xanthine carboxylate amides as A2A adenosine receptor ligands exhibiting bronchospasmolytic activity R Yadav, R Bansal, S Rohilla, S Kachler, KN Klotz Bioorganic Chemistry 65, 26-37, 2016 | 11 | 2016 |
| Synthesis, biological evaluation and molecular modelling studies of 1, 3, 7, 8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against … S Rohilla, R Bansal, S Kachler, KN Klotz Bioorganic Chemistry 87, 601-612, 2019 | 9 | 2019 |
| Piperidine nucleus as a promising scaffold for alzheimer’s disease: current landscape and future perspective P Grover, S Rohilla, M Bhardwaj, L Mehta, A Malhotra Current Topics in Medicinal Chemistry 23 (13), 1221-1259, 2023 | 6 | 2023 |
| Sulfonamides, quinolones, antiseptics, and disinfectants S Rohilla, D Sharma Medicinal Chemistry of Chemotherapeutic Agents, 21-63, 2023 | 5 | 2023 |
| A new series of 1, 3-dimethylxanthine based adenosine A2A receptor antagonists as a non-dopaminergic treatment of Parkinson’s disease S Rohilla, R Bansal, P Chauhan, S Kachler, KN Klotz Current Drug Discovery Technologies 18 (5), 7-17, 2021 | 4 | 2021 |
| Evaluation of anti-obesity potential of Commiphora mukul the indian bdellium plant DA Reddy, M Singh, S Babu, B Shrivastava, S Rohilla Annals of the Romanian Society for Cell Biology, 13802-13810, 2021 | 1 | 2021 |
| AN OVERVIEW OF BENEFITS OF COMMIPHORAMUKUL: THE INDIAN BDELLIUMPLANT. DA Reddy, SB Singh, B Shrivastava, S Rohilla European Journal of Molecular & Clinical Medicine 7 (10), 2020, 2020 | 1 | 2020 |
| Synthesis, Molecular Docking, and Biological Evaluation of Novel Indole-triazole Conjugates P Berwal, S Rohilla, N Mathur, K Rani Current Drug Discovery Technologies 21 (6), 115-129, 2024 | | 2024 |
| A Review on Indole-triazole Molecular Hybrids as a Leading Edge in Drug Discovery: Current Landscape and Future Perspectives S Rohilla, G Goyal, P Berwal, N Mathur Current Topics in Medicinal Chemistry 24 (18), 1557-1588, 2024 | | 2024 |
| Emerging Applications of Plant Antimicrobials in the Food Industry P Grover, M Bhardwaj, A Malhotra, R Sharma, A Pathak, C Genovese, ... Current Pharmaceutical Biotechnology, 2024 | | 2024 |
| Evaluation of Anti-Obesity Potential of Cappris Spinosa DA Reddy, M Singh, AMSS Babu, B Shrivastava, S Rohilla Annals of the Romanian Society for Cell Biology, 4384-4403, 2021 | | 2021 |
| Synthesis of novel A2a selective xanthine derivatives as antiparkinsonian agents R Bansal, S Rohilla, P Chauhan, KN Klotz ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
Ranju BansalProfessor of Pharmaceutical Chemistry, Panjab UniversityПодтвержден адрес электронной почты в домене pu.ac.in